Type-I interferon (IFNα/β) is the quintessential antiviral cytokine [22]–[24], and we hypothesized that the production of IFNα/β, particularly by the tumour stroma, was responsible for in vivo treatment resistance. The gene discussed is IFNA1; the disease is neoplasm.